Deep Track Capital’s Ambrx Biopharma Inc AMAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,710,412
Closed -$52.8M 79
2023
Q4
$52.8M Buy
+3,710,412
New +$42.2M 1.76% 22

Deep Track Capital's AMAM Position: Q1 2024 in Review

Deep Track Capital sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 3,710,412 shares — an estimated $52.8M sold.

Deep Track Capital first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $52.8M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

  • Deep Track Capital reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Deep Track Capital sold 3,710,412 Ambrx Biopharma Inc shares in Q1 2024, an estimated $52.8M.
  • Deep Track Capital first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
  • Deep Track Capital's Ambrx Biopharma Inc position peaked at $52.8M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Deep Track Capital's 13F filing for Q1 2024, filed 15 May 2024.